Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001005286-25-000033
Filing Date
2025-01-21
Accepted
2025-01-21 17:16:18
Documents
5
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A lfcr-proxyspecialcommittee.htm PRE 14A 239853
2 lifecorebiomedicalinc_vx001.jpg GRAPHIC 130142
3 lifecorebiomedicalinc_vx002.jpg GRAPHIC 144564
4 lifecorebiomedicalinc_vx003.jpg GRAPHIC 132118
5 lifecorebiomedicalinc_vx004.jpg GRAPHIC 146644
  Complete submission text file 0001005286-25-000033.txt   1003598
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: PRE 14A | Act: 34 | File No.: 000-27446 | Film No.: 25543313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)